Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
Rockwell Medical
RMTI
$28.4M
| $213K | ﹤0.01% |
992
+7
| +0.7% | +$1.65K |
|
|
HBMD
4902
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $213K | ﹤0.01% |
20,119
+3,908
| +24% | +$39.9K |
|
|
YDKG
4903
Yueda Digital Holding
YDKG
$5.81M
| $212K | ﹤0.01% |
671
+111
| +20% | +$34.7K |
|
|
JHMT
4904
DELISTED
John Hancock Multifactor Technology ETF
JHMT
| $211K | ﹤0.01% |
3,494
+277
| +9% | +$15.2K |
|
4905
FRP Holdings
FRPH
$428M
| $210K | ﹤0.01% |
10,362
+9,084
| +711% | +$188K |
|
4906
Schwab 1000 Index ETF
SCHK
$5.71B
| $210K | ﹤0.01% |
13,802
+12,808
| +1,289% | +$183K |
|
4907
First Financial Corp
THFF
$958M
| $210K | ﹤0.01% |
5,692
+3,070
| +117% | +$104K |
|
4908
Altimmune
ALT
$552M
| $209K | ﹤0.01% |
19,486
+11,764
| +152% | +$64.6K |
|
|
HNW
4909
DELISTED
Pioneer Diversified High Income Fund
HNW
| $209K | ﹤0.01% |
17,362
-2,237
| -11% | -$25.3K |
|
4910
KORU Medical Systems
KRMD
$189M
| $208K | ﹤0.01% |
23,084
+9,912
| +75% | +$100K |
|
4911
News Corp Class B
NWS
$16.9B
| $207K | ﹤0.01% |
17,284
-10,006
| -37% | -$108K |
|
4912
iShares US Small Cap Equity Factor ETF
SMLF
$4.09B
| $207K | ﹤0.01% |
5,787
-596
| -9% | -$19.9K |
|
4913
Tidewater
TDW
$3.73B
| $207K | ﹤0.01% |
37,048
+16,915
| +84% | +$96.1K |
|
4914
McEwen Inc
MUX
$1.03B
| $206K | ﹤0.01% |
20,438
+7,748
| +61% | +$72K |
|
|
PROF
4915
Profound Medical
PROF
$268M
| $206K | ﹤0.01% |
12,180
-1,008
| -8% | -$12.7K |
|
4916
Anavex Life Sciences
AVXL
$255M
| $205K | ﹤0.01% |
41,711
+12,899
| +45% | +$48.7K |
|
4917
LiqTech
LIQT
$23M
| $205K | ﹤0.01% |
4,688
-1,125
| -19% | -$46.9K |
|
4918
Stellus Capital Investment Corp
SCM
$217M
| $204K | ﹤0.01% |
28,000
-3,914
| -12% | -$29.7K |
|
4919
Timberland Bancorp
TSBK
$348M
| $204K | ﹤0.01% |
11,227
+1,918
| +21% | +$33.4K |
|
4920
Orrstown Financial Services
ORRF
$840M
| $203K | ﹤0.01% |
13,735
+2,749
| +25% | +$36.7K |
|
|
KSM
4921
DELISTED
DWS Strategic Municipal Income Trust
KSM
| $203K | ﹤0.01% |
19,292
+1,609
| +9% | +$16.4K |
|
4922
First Trust Developed Markets ex-US Small Cap AlphaDEX Fund
FDTS
$12.9M
| $202K | ﹤0.01% |
6,182
+37
| +0.6% | +$1.12K |
|
4923
Northern Oil and Gas
NOG
$2.3B
| $202K | ﹤0.01% |
24,101
+8,283
| +52% | +$70.8K |
|
4924
X4 Pharmaceuticals
XFOR
$375M
| $202K | ﹤0.01% |
724
+589
| +436% | +$161K |
|
|
PVLA
4925
Palvella Therapeutics
PVLA
$1.99B
| $202K | ﹤0.01% |
814
-4,189
| -84% | -$980K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.